News

Lighthouse Labs rebrands as Lighthouse Network, shifts focus to long-term founder development

Longtime Richmond accelerator Lighthouse Labs is rebranding to better reflect its commitment to startup founders.

The organization will now be known as Lighthouse Network and will make a “renewed focus” on long-term, human-centered development of founders, it said in its announcement.

“We’ve always believed that when founders thrive, so do their companies,” Debbie Irwin, who became the organization’s executive director in February 2024, said in a statement. “This transition to Lighthouse Network reflects what we’ve been doing for years — walking alongside founders, helping them navigate the messy middle and building the kind of trust and support systems that aren’t found in a typical accelerator.”

The changes include year-round founder support through mentorship, curated investor connections and targeted programming. That will include strategic events like its Founder Network Summit, Investor Connect and Demo Day. Lighthouse will host just one accelerator cohort per year, something it announced in February when it announced the program’s 18th cohort. It previously hosted two a year.

In the past, companies received $20,000 in equity-free financing for being selected to a cohort. But that ended this year, and it instead expanded what it calls “high-impact services” like fractional CFO support, mental health resources and deeper relationship building with investors.

Lighthouse said it will also work to grow a national network rooted in Richmond of founders, mentors and partners committed more to long-term success as opposed to short-term outcomes.

Along with the new name, the rebrand includes a new visual identity, messaging and website that Lighthouse says better reflects its broader vision and nationwide push.

“This isn’t just a name change,” Irwin said in a statement. “It’s a commitment to the people building bold ideas — and a recognition that founders need more than funding to succeed. They need community, connection and a place that sees them as humans first.”

Read more here.

Recent News

05/18/2026

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the completion of its acquisition of Soleno Therapeutics, Inc., strengthening the company’s leadership in endocrinology and rare disease. The acquisition adds VYKAT™ XR (diazoxide choline) tablets, the first and only approved medicine for hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome, to

05/15/2026

OsteoStrong Expands in Virginia with New Location in Tysons, Virginia

OsteoStrong, a global leader in skeletal strength conditioning, is expanding in Northern Virginia with a new location in Tysons, Virginia, offering residents a cutting-edge, drug-free solution to improve bone density, strength and overall skeletal health in just 10-minute sessions per week. Located at 8609 Westwood Center Drive, Suite 625, Vienna, VA 22182, OsteoStrong Tysons VA

05/15/2026

ATCC Wins Prestigious National Institutes of Health Replication Prize for Advancing Reproducibility in Virus Research

ATCC is a winner of the National Institutes of Health (NIH) Common Fund Replication Prize, a prestigious national competition designed to advance scientific research by identifying strategies to make biomedical research more replicable. ATCC is recognized as one of 35 winners, and one of 15 selected winners for the Replication Exemplars Track. ATCC was recognized